Bromide

Bromide

SCHEMBL384556

CN(C)c1cc[n+](C#N)cc1.[Br-]

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ CHKA known ✓ P35790 10/20 0.47
▸ ALDH1A1 P00352 6/20 0.43
▸ TSHR P16473 2/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ MAPT P10636 2/20 0.42
▸ LMNA P02545 2/20 0.41
▸ HTT P42858 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1063959 0.98 ALDH1A1 (0.46) CHKAALDH1A1TSHRALOX15HSD17B10
Hydrochloric Acid SCHEMBL29199774 0.95 ALDH1A1 (0.43) CHKAALDH1A1TSHRALOX15HSD17B10
SCHEMBL161677 0.90 ALDH1A1 (0.39) CHKAALDH1A1TSHRALOX15HSD17B10
SCHEMBL4531332 0.90 ALDH1A1 (0.39) CHKAALDH1A1TSHRALOX15HSD17B10
SCHEMBL1185630 0.88 CHKA (0.41) CHKAALDH1A1TSHRALOX15HSD17B10
SCHEMBL1185633 0.86 CHKA (0.36) CHKAALDH1A1TSHRALOX15HSD17B10
SCHEMBL7995708 0.86 CHKA (0.36) CHKAALDH1A1TSHRALOX15HSD17B10
Acetonitrile SCHEMBL28221268 0.86 CHKA (0.36) CHKAALDH1A1TSHRALOX15HSD17B10
SCHEMBL3630115 0.86 CHKA (0.36) CHKAALDH1A1TSHRALOX15HSD17B10
Trifluoromethanesulfonic Acid SCHEMBL4459808 0.79 NSD2 (0.37) ALDH1A1TSHRALOX15HSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117945893-A Method for separating succinic acid and adipic acid mixture 开滦(集团)有限责任公司 2024-04-30 — — CN claimed
WO-2023069278-A1 CHEMICAL REAGENTS FOR THE ACTIVATION OF POLYSACCHARIDES IN THE PREPARATION OF CONJUGATE VACCINES FINA BIOSOLUTIONS, LLC (US) 2023-04-27 — — WO claimed
US-20230122876-A1 Chemical Reagents for the Activation of Polysaccharides in the Preparation of Conjugate Vaccines FINA BIOSOLUTIONS, LLC (US) 2023-04-20 — — US claimed
CN-117945893-A Method for separating succinic acid and adipic acid mixture 开滦(集团)有限责任公司 2024-04-30 — — CN disclosed
WO-2023069278-A1 CHEMICAL REAGENTS FOR THE ACTIVATION OF POLYSACCHARIDES IN THE PREPARATION OF CONJUGATE VACCINES FINA BIOSOLUTIONS, LLC (US) 2023-04-27 — — WO disclosed
WO-2023069278-A1 CHEMICAL REAGENTS FOR THE ACTIVATION OF POLYSACCHARIDES IN THE PREPARATION OF CONJUGATE VACCINES FINA BIOSOLUTIONS, LLC (US) 2023-04-27 — — WO disclosed
US-20230122876-A1 Chemical Reagents for the Activation of Polysaccharides in the Preparation of Conjugate Vaccines FINA BIOSOLUTIONS, LLC (US) 2023-04-20 — — US disclosed
US-20230122876-A1 Chemical Reagents for the Activation of Polysaccharides in the Preparation of Conjugate Vaccines FINA BIOSOLUTIONS, LLC (US) 2023-04-20 — — US disclosed
US-10444220-B2 Controlled tunnel gap device for sequencing polymers ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2019-10-15 — — US disclosed
US-20180224422-A1 CONTROLLED TUNNEL GAP DEVICE FOR SEQUENCING POLYMERS ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2018-08-09 — — US disclosed
US-9810681-B2 Controlled tunnel gap device for sequencing polymers ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2017-11-07 — — US disclosed
EP-1044372-B1 Method for determining an analyte in a sample using a flow matrix which comprises addition of reagents at two or more positions of the matrix PHARMACIA DIAGNOSTICS AB (SE) 2003-09-03 — — EP disclosed
EP-1305327-A2 TRIPHOSPHATE OLIGONUCLEOTIDE MODIFICATION REAGENTS AND USES THEREOF Schwartz, David A. (US) 2003-05-02 — — EP disclosed
WO-2002010432-A2 TRIPHOSPHATE OLIGONUCLEOTIDE MODIFICATION REAGENTS AND USES THEREOF SCHWARTZ DAVID A (US) 2002-02-07 — — WO disclosed
WO-2002010431-A2 FUNCTIONAL BIOPOLYMER MODIFICATION REAGENTS AND USES THEREOF SCHWARTZ DAVID A (US) 2002-02-07 — — WO disclosed
EP-1044372-A1 ANALYTICAL METHOD COMPRISING ADDITION IN TWO OR MORE POSITIONS AND A DEVICE AND TEST KIT THEREFOR Pharmacia & Upjohn Diagnostics AB (SE) 2000-10-18 — — EP disclosed
EP-1044376-A1 ANALYTICAL METHOD USING PARTICLES AND TEST KIT FOR PERFORMING THE METHOD Pharmacia & Upjohn Diagnostics AB (SE) 2000-10-18 — — EP disclosed
WO-1999036780-A1 ANALYTICAL METHOD USING PARTICLES AND TEST KIT FOR PERFORMING THE METHOD PHARMACIA & UPJOHN DIAGNOSTICS AB (SE) 1999-07-22 — — WO disclosed
WO-1999036776-A1 ANALYTICAL METHOD COMPRISING ADDITION IN TWO OR MORE POSITIONS AND A DEVICE AND TEST KIT THEREFOR PHARMACIA & UPJOHN DIAGNOSTICS AB (SE) 1999-07-22 — — WO disclosed
WO-1998001545-A1 MODIFIED LACTATE DEHYDROGENASE, PROCESS FOR ITS PREPARATION AND ITS USE BOEHRINGER MANNHEIM GMBH (DE) 1998-01-15 — — WO disclosed
Send feedback